Gyre Therapeutics, Inc. GYRE Intangible Purchases
Intangible Purchases at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s intangible purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s intangible purchases?
- Gyre Therapeutics, Inc. (GYRE) reported intangible purchases of $5K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s intangible purchases changed year-over-year?
- Gyre Therapeutics, Inc.'s intangible purchases decreased by 99.3% year-over-year, from $699K to $5K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s intangible purchases?
- Over 2 years (2022 to 2025), Gyre Therapeutics, Inc.'s intangible purchases has grown at a 652.9% compound annual growth rate (CAGR), from $13K to $737K.
- What does intangible purchases mean?
- Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.